KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxlinear (MXL) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Maxlinear (MXL) over the last 17 years, with Q4 2025 value amounting to $492000.0.

  • Maxlinear's Gains from Investment Securities rose 10788.71% to $492000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.7 million, marking a year-over-year decrease of 1424.62%. This contributed to the annual value of -$3.7 million for FY2025, which is 1424.62% down from last year.
  • Maxlinear's Gains from Investment Securities amounted to $492000.0 in Q4 2025, which was up 10788.71% from -$6.5 million recorded in Q3 2025.
  • Maxlinear's Gains from Investment Securities' 5-year high stood at $24.4 million during Q1 2022, with a 5-year trough of -$6.5 million in Q3 2025.
  • In the last 5 years, Maxlinear's Gains from Investment Securities had a median value of $1.7 million in 2021 and averaged $2.4 million.
  • Per our database at Business Quant, Maxlinear's Gains from Investment Securities skyrocketed by 146673.68% in 2021 and then crashed by 293545.45% in 2024.
  • Maxlinear's Gains from Investment Securities (Quarter) stood at $2.1 million in 2021, then crashed by 82.16% to $369000.0 in 2022, then tumbled by 40.38% to $220000.0 in 2023, then plummeted by 2935.45% to -$6.2 million in 2024, then surged by 107.89% to $492000.0 in 2025.
  • Its Gains from Investment Securities stands at $492000.0 for Q4 2025, versus -$6.5 million for Q3 2025 and $144000.0 for Q2 2025.